Viewing Gene With Clinical Trials Data

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Report Bug Request Feature
Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol: PAH
Name: phenylalanine hydroxylase
Location: 12q23.2
Locus Group: protein-coding gene
Gene Type: Protein Coding
Locus Type: gene with protein product
ID+ Clinical Trials CompTox DrugMatrix Conditions Design Enrollment Locations Outcomes
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all

Clinical Studies

NCT Number Status Brief Title View
NCT04768348 Natural History Clinical Study in Adult PKU View
NCT04227080 BH4 Responsiveness in PAH Deficiency PKU Patients View
NCT00319267 Bosentan in Children With Pulmonary Arterial Hypertension View
NCT00327080 Sildenafil to Treat HIV-Associated Pulmonary Hypertension View
NCT00342472 Environmental and Biological Monitoring Pilot Study for Polycyclic Aromatic Hydrocarbons in Linxian China View
NCT00367523 Pulmonary Hypertension in Patients With Sickle Cell Disease in Nigeria View
NCT00454558 An Open Multiple Dose Titration Study In Patients With Pulmonary Hypertension View
NCT00477269 Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension View
NCT00482118 Smoky Coal Exposure Genetic Susceptibility and Lung Cancer in Non-Smoking Women in China View
NCT00688844 Nutritional and Neurotransmitter Changes in PKU Subjects on BH4 View
NCT00690014 Evaluation of Renal Drug Transport in Healthy Volunteers View
NCT00706082 Early Simple and Reliable Detection of Pulmonary Arterial Hypertension PAH in Systemic Sclerosis SSc View
NCT01557647 Safety and Efficacy of Inhaled Treprostinil in Patients With PAH View
NCT01560624 Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy View
NCT03809156 Upfront Combination Pulmonary Arterial Hypertension Therapy View
NCT04915300 Apabetalone for Pulmonary Arterial Hypertension View
NCT01268553 Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication View
NCT01318967 Measurement of Kidney Blood Flow and Oxygen Levels by MRI View
NCT01347216 COMPERA COMPERA-KIDS View
NCT01581086 Vascular Subphenotypes of Lung Disease in HIV COPD View
NCT01451255 Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance Imaging View
NCT01470144 Epoprostenol for Injection in Patients With Pulmonary Arterial Hypertension View
NCT04224012 Effect of Exercise and Respiratory Therapy on Right Ventricular Function in Severe Pulmonary Hypertension View
NCT01484431 A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension View
NCT01649739 Vardenafil as add-on Therapy for Patients With Pulmonary Hypertension Treated With Inhaled Iloprost View
NCT03612544 The ESTxENDS Trial- Substudy on the Effect on Toxins From Using Electronic Nicotine Delivery Systems ENDSVaporizerE-cig View
NCT02845518 Study of Cardiac MRI in the Follow up Assessment of Patients With PAH EVITA View
NCT01827059 Bosentan In Exercise Induced Pulmonary Arterial Hypertension in CongenitaL Heart diseasE View
NCT03744637 A Study of Single Doses of MK -5475 on Pulmonary Vascular Resistance MK-5475-002 View
NCT01913457 Measurements and Characterization of Doppler Signals From the Right Chest in Pediatric and Adult Patients View
NCT01950585 Hydroxyurea in Pulmonary Arterial Hypertension View
NCT02023450 Testing of HIV Protease Inhibitors to Suppress Inflammation and Improve Cardio Pulmonary Hemodynamics in Subjects With Pulmonary Arterial Hypertension View
NCT04086511 PANDA PKU Amino Acid Evaluation View
NCT04254289 Pilot Randomized Trial of Ambulatory Exercise in Pulmonary Hypertension View
NCT02576002 Epidemiology and Treatment Patterns of Paediatric PAH Pulmonary Arterial Hypertension View
NCT00467896 The Power 15 Study Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting View
NCT04265547 Family-Based Intervention Study of the Effects of Environmental Exposures on Breast Tissue Composition View
NCT02782052 Bronchodilators Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertension View
NCT04266197 Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study View
NCT03055221 TRUST-2 Safety and Efficacy of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension PAH View
NCT06483490 Environmental Pollutants in COPD and Lung Cancer View
NCT03251872 Olaparib for PAH a Pilot Study View
NCT03270332 Effect of Inhaled Albuterol in Pulmonary Hypertension View
NCT03078907 Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension View
NCT03593005 Acute Exposure to High Altitude on Symptoms View
NCT03637127 Acute Exposure of Simulated Hypoxia on Cognitive Function View
NCT03637218 Acute Exposure of High Altitude on Cardiac Output View
NCT03637088 Acute Exposure of Simulated Hypoxia on Pulmonary Artery Pressure and Right Heart Function Echo View
NCT03637153 Acute Exposure to High Altitude on Exercise Capacity View
NCT03672591 Renal Hemodynamics in Patients With HFpEF View
NCT03905083 miRNA and Myokines in Patients With PAH View
NCT03928002 4DFlow Magnetic Resonance Imaging in Patients With Pulmonary Hypertension Associated With Congenital Heart Disease View
NCT03979482 Skeletal Muscle Mitochondrial Abnormalities and the Metabolic Syndrome in PAH View
NCT04006106 Defining ENDOtypes in Perioperative Hypersensitivity by Extensive Cellular and Molecular PHENotyping ENDOPHEN View
NCT04125745 Oral CXA-10 in Pulmonary Arterial Hypertension View
NCT05716984 rhBNP in Type 3 Pulmonary Hypertension View
NCT04194632 Right Ventricular Pacing in Pulmonary Arterial Hypertension View
NCT04280523 TranspulmonarY Estrogen Gradient and Estrogen Receptors TYEGER in PAH View
NCT04390126 COVID-19 Related Lockdown Effects On Chronic Diseases View
NCT04407481 PErfusioN OxyGen ConsUmptIon and ENergetics in ADPKD PENGUIN View
NCT04780932 Initial Dual Oral Combination Therapy Versus Standard-of-care Initial Oral Monotherapy Prior to Balloon Pulmonary Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension View
NCT04813926 A Study to Learn About How Well Riociguat Works How Safe it is and How it is Used Under Real World Conditions in Patients in the United States Who Are Receiving Riociguat for High Blood Pressure in the Arteries That Carry Blood From the Heart to the Lungs Pulmonary Arterial Hypertension PAH View
NCT05890651 Holter and ECG Changes After Transcatheter Closure Of VSD In Children View
NCT02768259 Prevalence of Pulmonary Arterial Hypertension in Patients With Connective Tissue Diseases in Egyptian Patients View
NCT05029167 REstrictive Versus LIberal Oxygen Strategy and Its Effect on Pulmonary Hypertension After Out-of-hospital Cardiac Arrest RELIEPH-study View
NCT06051396 Phenotyping of the Out-of-proportion Pulmonary Hypertension View
NCT01330108 Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension View
NCT05209919 Echocardiographic Assessment and CLInical imPlication of Functional tricuSpid rEgurgitation in Heart Failure With Reduced or Preserved Ejection Fraction View
NCT06258850 REstoration of VItamin D in Pulmonary Arterial Hypertension View
NCT01083524 Dichloroacetate DCA for the Treatment of Pulmonary Arterial Hypertension View
NCT05618093 Non-Invasive Measurement of Cardiac Output and Stroke Volume in PAHCTEPH View
NCT00071461 Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis View
NCT01086540 Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension SSc-PAH View
NCT00091598 ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension PAH View
NCT05105555 The e-BILD Study Effects of E-cigarettes on Lung Health in Teenagers View
NCT02344602 The Effect of Uric Acid Lowering in Type 1 Diabetes View
NCT05968859 A Study of Pulmonary Hypertension Peripheral Limitations View
NCT01100736 Role of Endothelin-A ETA and Endothelin-B ETB Receptors in the Vasodilatory Response to Endothelin-3 ET-3 View
NCT06060366 Impact of Pulmonary Endarterectomy on Sleep-Related Breathing Disorders in CTEPH The IPES Trial View
NCT06119048 Phe for Me The Effects of L-Phe on PKU Carriers and Non-carriers View
NCT01105091 Epoprostenol for Injection in Pulmonary Arterial Hypertension View
NCT00380068 Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension View
NCT06213688 Involvement of Pollutants in Atopic Dermatitis and Psoriasis View
NCT06274801 Open-label Extension Study of Seralutinib in Adult Subjects With PAH PROSERA-EXT View
NCT06312111 Physical Activity and Various Aspects of Quality of Life in Patients With Pulmonary Arterial Hypertension Ph-PAH View
NCT01112306 ACT-293987 in Pulmonary Arterial Hypertension View
NCT06549452 Mobile Health Intervention to Improve Exercise in Pediatric PH View
NCT03205085 Determinants of Right Heart Remodeling in Patients With CTEPH or PAH View
NCT05995743 VO2max HRQoL in Children With Sickle Cell Disease View
NCT04074668 Control of Renal Oxygen Consumption Mitochondrial Dysfunction and Insulin Resistance View
NCT05437224 Efficacy and Safety Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension View
NCT02899533 18FFES PETCT in PAH View
NCT03403868 Right Ventricular Haemodynamic Evaluation and Response to Treatment View
NCT03571555 Prospective Cohort Study of Adolescents Living With HIV and Their Caregivers Attending a Psychosocial Programme in Botswana View
NCT03581851 Acute Exposure of Simulated Hypoxia on ECG and Non-invasive Blood Pressure View
NCT06429579 Potts-shunt for the Treatment of Pediatric Patients With Severe Pulmonary Hypertension View
NCT01105117 Epoprostenol for Injection in Pulmonary Arterial Hypertension - Extension of AC-066A401 View
NCT00423748 Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension View
NCT00435331 6R-BH4 Pulmonary Arterial Hypertension Study View
NCT00433329 Combination Therapy in Pulmonary Arterial Hypertension View
NCT00439946 Safety Efficacy and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH View
NCT01181284 Modulating Effects of Lisinopril on Sildenafil Activity in Pulmonary Arterial HypertensionPAH MELISSA View
NCT00044603 Vulnerability of the FetusInfant to PAH PM25 AND ETS View
NCT00458042 Transitioning To IV Remodulin From Ventavis in Patients With PAH Safety Efficacy and Treatment Satisfaction View
NCT00370214 REVEAL Registry Registry to Evaluate Early And Long-term PAH Disease Management View
NCT00086463 Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension PAH View
NCT00082186 The Effect of Tracleer on Male Fertility View
NCT01302444 Treprostinil Combined With Tadalafil for Pulmonary Hypertension View
NCT01319045 Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart Disease View
NCT00159874 A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension PAH In Children View
NCT02911844 Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension View
NCT00091715 Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II View
NCT00042445 Brain Neoplasms Leukemia and Petrochemical Exposures View
NCT01880866 --Epicatechin and Pulmonary Arterial Hypertension View
NCT01365585 Evaluate The Clinical Effectiveness Safety And Tolerability Of Sildenafil Used In Doses 20mg TID For The Treatment Of Pulmonary Arterial Hypertension View
NCT00323024 Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial Hypertension View
NCT00323297 Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension View
NCT00345774 Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease View
NCT04416750 Positioning Imatinib for Pulmonary Arterial Hypertension View
NCT00367770 BREATHE 5-OL Tracleer Bosentan in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology View
NCT00373360 Safety Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin View
NCT01391104 Responsiveness of Exercise Tests in Pulmonary Arterial Hypertension View
NCT00384865 A Study of Aspirin and Simvastatin in Pulmonary Arterial Hypertension View
NCT00423202 A Phase 3 Randomized Double-Blind Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension View
NCT00423592 Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension View
NCT02471183 Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial Hypertension View
NCT00453414 Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension View
NCT00452218 Sorafenib Study Dosing in Patients With Pulmonary Arterial Hypertension PAH View
NCT00454207 Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension View
NCT00469027 Pulmonary Hypertension Assessment of Cell Therapy View
NCT04456998 GB002 in Adult Subjects With Pulmonary Arterial Hypertension PAH View
NCT01468545 Educational Training Influence in Patients With PAHPulmonary Artery Hypertension on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT System View
NCT00494533 Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension View
NCT01484899 Smoking a Risk Factor for Pulmonary Arterial Hypertension View
NCT01496963 Prevalence of Pulmonary Hypertension PAH in Patients With Thalassemia View
NCT00430716 To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension View
NCT01795950 Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension PAH View
NCT00554619 A Study to Evaluate GSK1325760A - a Long-Term Extension Study View
NCT01800292 Characterization of LV Strain Patterns in Mildly Elevated PCWP and PAH View
NCT01523548 Carbon Monoxide Therapy for Severe Pulmonary Arterial Hypertension View
NCT00625963 The Study Of CT Scans and Echo Parameters in Patients With PAH View
NCT00625079 Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil View
NCT00625469 Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan View
NCT00667823 Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension View
NCT01560637 An Open-Label Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension View
NCT00434902 Evaluation of the Prevalence of Pulmonary Hypertension in Adult Patients With Sickle Cell Disease View
NCT00680654 Interaction Study in Patients With Pulmonary Hypertension and Stable Treatment of Sildenafil 20 mg TID View
NCT00709098 Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension View
NCT00709956 Iloprost Power 15 in Pulmonary Arterial Hypertension View
NCT00728676 Study to Evaluate the Effects of Kuvan on Individuals With Phenylketonuria PKU With Maladaptive Behaviors View
NCT00741819 Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension PAH Subjects View
NCT02759419 A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension View
NCT01607489 Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography View
NCT01600898 Screening of Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers View
NCT00792571 An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension PAH Patients View
NCT00796666 Study Looking at Combination Therapy SitaxsentanSildenafil Vs Monotherapy Sitaxsentan Alone SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil View
NCT00796510 Study Providing Monotherapy Sitaxsentan And Combination Therapy SitaxsentanSildenafil To Subjects With Pulmonary Arterial Hypertension PAH To Assess Long-Term Safety View
NCT00806312 The Expression and Significance of MiRNA View
NCT02191137 Measuring Outcomes In Patients With Pulmonary Arterial Hypertension Not on Active Treatment MOTION View
NCT02032836 Comparative PK PD Study in PAH Patients Fox vs I-Neb View
NCT00853112 A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension View
NCT02648984 Evaluation of Dynamic Pulmonary Vascular Resistance in Patients With Closed Ventricular Septal Defect View
NCT00856960 The Effect of Hypertension Medications on Renal Blood Flow Measurements in Healthy Males MK-0000-127 View
NCT00863681 BAY63-2521Long-term Extension Study in Patients With Pulmonary Arterial Hypertension View
NCT00864201 A Study to Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue Disease View
NCT01642407 Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension View
NCT00866983 Local Open-Label Access Study For Patients Who Completed A1481244 Study In Brazil View
NCT02309463 Correlation of LONGterm Wrist ACTigraphy Recorded Physical Performance 6-minute Walk Distance in Patients With Pulmonary Arterial Hypertension View
NCT00902174 Imatinib QTI571 in Pulmonary Arterial Hypertension View
NCT00936416 Assessment of Renal Physiology by Magnetic Resonance Imaging MRI in Normal Volunteers View
NCT02631421 Dysregulation of Lipid Metabolism and Right Ventricular Function in PAH View
NCT00946114 To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 Weeks View
NCT00544726 Rehabilitation for Patients With Pulmonary Arterial Hypertension View
NCT02220023 Dynamic Assessment of Right Ventricular Function With Inhaled Nitric Oxide During Cardiac MRI View
NCT00989963 Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release BPS-MR in Patients With Pulmonary Arterial Hypertension PAH View
NCT00984932 Effect of Rosuvastatin on Systemic Sclerosis-related Pulmonary Hypertension View
NCT02080533 Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial Hypertension View
NCT00993408 Study of ACT-293987 NS-304 in Pulmonary Arterial Hypertension PAH View
NCT02551653 Positron Emission Tomography PET Study to Evaluate Biodistribution of 11C-GSK2256098 in Healthy Subjects and Idiopathic Pulmonary Arterial Hypertension PAH Patients View
NCT02638922 Evaluation and Treatment of Tall Statured Girls View
NCT02237378 A Pilot Study Evaluating Heart and Lung Metabolism in Pulmonary Hypertension Associated With Left Heart Disease View
NCT01051960 Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan View
NCT01066845 Post Marketing Observational Study in Patients With Pulmonary Arterial Hypertension View
NCT02691689 Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions View
NCT02253394 The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study View
NCT01106014 Selexipag ACT-293987 in Pulmonary Arterial Hypertension View
NCT02120339 Carvedilol PAH A Pilot Study of Efficacy and Safety View
NCT01117987 Extension to QTI571A2301 to Evaluate the Long-term Safety Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension PAH View
NCT00990314 Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension PAH Patients View
NCT01712997 Study of the Initial Combination of Bosentan With Iloprost in the Treatment of Pulmonary Hypertension Patients View
NCT01712620 Spironolactone for Pulmonary Arterial Hypertension View
NCT01210443 Long-Term Open-Label Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients View
NCT01156220 Investigation of Gender Specificity of the Effects of Furosemide in Healthy Female and Male Volunteers View
NCT01729611 Endothelial Function in Patients With Scleroderma or Cirrhosis With and Without Pulmonary Hypertension View
NCT04732221 A Study of the Efficacy and Safety of MK-5475 in Participants With Pulmonary Arterial Hypertension INSIGNIA-PAH Phase 23 Study of an Inhaled sGC Stimulator in PAH MK-5475-007 View
NCT04732650 Real World Difference After Changing Medication From Nonselective to Selective Endothelin Receptor Antagonist in Stable Eisenmenger Syndrome View
NCT01517854 Revatio Portal-Pulmonary Arterial Hypertension Trial View
NCT01179737 Efficacy Safety Tolerability and Pharmacokinetics PK of Nilotinib AMN107 in Pulmonary Arterial Hypertension PAH View
NCT01723371 Beta Blockers for Treatment of Pulmonary Arterial Hypertension in Children View
NCT01730092 Natural History Study of Biomarkers in Pulmonary Arterial Hypertension View
NCT01208792 Auto-immunity and Pulmonary Arterial Hypertension View
NCT02652429 Long-Term Extension Study of Inhaled Nitric Oxide iNO for PAH View
NCT02821156 Study on the Use of Inhaled NO iNO View
NCT01223352 Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension View
NCT01247116 First-line Bosentan and Sildenafil Combination Therapy for Pulmonary Arterial Hypertension View
NCT02290613 Early Treatment of Borderline Pulmonary Arterial Hypertension Associated With Systemic Sclerosis SSc-APAH View
NCT01266265 Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso Compared to Other FDA Approved PAH Therapies View
NCT01265888 Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl View
NCT04787445 Effects of Pulmonary Hypertension Therapy in Atypical Pulmonary Arterial Hypertension View
NCT01338415 FUTURE 3 Study Extension View
NCT01338636 An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Participants With Exercise-Induced Pulmonary Arterial Hypertension PAH View
NCT01763112 Training With Whole Body Vibration Device in Patients With PAH View
NCT01389206 Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program View
NCT01383083 Effects of Iloprost Treatment in Adult Patients With Pulmonary Arterial Hypertension Related to Congenital Heart Disease View
NCT01382368 Acute Effect of Sildenafil on Exercise Tolerance and Functional Capacity in COPD IPF and Post Pneumonectomy Patients View
NCT02657356 Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST View
NCT01423071 Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension Prevalence and Quality of Life View
NCT01445873 Pilot Chart Review Study Of Sitaxentan Sodium Thelin In Patients With Pulmonary Arterial Hypertension PAH View
NCT01457781 Inhaled Nitric OxideINOpulse DS for Pulmonary Arterial Hypertension PAH View
NCT01469169 Inhaled Iloprost Ventavis Efficacy Safety and Pharmacokinetics PK Confirmation Study View
NCT01462565 Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension PAH View
NCT01468792 Hemodynamic Changes in Connective Tissue Disease View
NCT01508780 Combined Use of Angiography Optical Coherence Tomography and Intravascular Ultrasound in Evaluation of Pulmonary Vascular Structure and Function in Patients With Pulmonary Arterial Hypertension Treated With Oral Bosentan View
NCT04908397 Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension View
NCT01545336 Anastrozole in Patients With Pulmonary Arterial Hypertension View
NCT01553721 Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial HypertensionPAH View
NCT01557660 Inhaled Treprostinil for PAH Open-label Extension View
NCT01557582 Assessmet of Patients With PAH Right Ventricular Volume View
NCT01572077 Rt Ventricular Substrate Metabolism as a Predictor of Rt Heart Failure in Patients With Pulmonary Arterial Hypertension View
NCT01582438 An Open Label Access Study For Subjects Who Completed A1481156 View
NCT01588405 Remodulin to Oral Treprostinil Transition View
NCT04954742 Effects of Riociguat on RIght VEntricular Size and Function in PAH and CTEPH View
NCT01586156 PAHTCH Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure Carvedilol View
NCT04955990 A Study of Real-world Cohort of Pulmonary Arterial Hypertension PAH Participants View
NCT04968210 Metabolic Remodeling in Pulmonary Arterial Hypertension PAH View
NCT02949141 Diagnostic Use of Lung Ultrasound for Suspected Pneumonia in Nepal View
NCT03045666 Impact of Rehabilitation Program on PAH Patients Treated With Macitentan View
NCT04991454 Xenon MRI Pulm Hypertension View
NCT03053739 To Compare the Efficacy of Combination Therapy vs Monotherapy for Pulmonary Arterial Hypertension in Systemic Sclerosis View
NCT01647945 FK506 Tacrolimus in Pulmonary Arterial Hypertension View
NCT04053296 Long-term Outcomes of Pregnant Women With PAH View
NCT05060315 Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin View
NCT01725269 Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05 View
NCT01725256 A Phase 2 Study to Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension PAH View
NCT01757808 A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension View
NCT03001414 Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension Intervention With Repeat Dosing of eNOS-enhanced EPCs View
NCT05096819 Evaluation of the Usefulness of Adopting Remote Mobile-based 6MWT Among Hospital Outpatients the 6-APPnow Within the Constraints Imposed by the SARS-COV2 Pandemic View
NCT01799473 Tyvaso Dosing and Titration Evaluation TyTRATE Registry View
NCT01808313 Efficacy Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension PAH View
NCT03139084 Efficacy and Safety of Upfront Combination of ΒΟsentan and ΤΑdalafil in Pulmonary Arterial Hypertension View
NCT04175600 A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension View
NCT03476629 Effects of Different Types of Physical Training in Patients With Pulmonary Arterial Hypertension View
NCT01835080 Obstructive Sleep Apnea OSA in Pulmonary Arterial Hypertension PAH View
NCT01841762 Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument View
NCT01847014 Clinical Study of Macitentan in Patients With PAH to Psychometrically Validate PAH-SYMPACT Instrument View
NCT01884051 Hormonal Metabolic and Signaling Interactions in PAH View
NCT01894035 Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension PAH With Inhaled Iloprost Using I-Neb as a Device for Inhalation View
NCT01908699 Beraprost-314d Added-on to Tyvaso BEAT View
NCT01924026 Neurocognitive Outcomes in Mild Hyperphenylalaninemia MHPMHP Study View
NCT01926509 Study to Assess the Safety Tolerability and Pharmacokinetics PK of MK-8892 in Participants With Pulmonary Arterial Hypertension PAH MK-8892-005 View
NCT01934647 Acute Dosing of MK-8892 in Participants With Pulmonary Arterial Hypertension PAH MK-8892-003 View
NCT05224531 Effect of CS1 in Subjects With Pulmonary Arterial Hypertension View
NCT01955954 Using the Canary Breathing System for Panic Disorder Patients View
NCT01959815 Novel Screening Strategies for Scleroderma PAH View
NCT01979822 LenusPro Safety LPS Study in Patients With PH View
NCT02000856 BEET PAH a Study to Assess the Effects of Beetroot Juice in Patients With Pulmonary Arterial Hypertension View
NCT03362047 RIGHT HEART III Study - Right Ventricular Hemodynamic Evaluation and Response to Treatment View
NCT05318950 A nUtrition and Lifestyle Intervention in Patients With Pulmonary Arterial HypertensIon View
NCT00551408 Endothelial Progenitor Cells and Pulmonary Idiopathic Arterial Hypertension View
NCT05332847 Point of Care Ultrasonography Assessment During Pulmonary Hypertension Clinic View
NCT05343091 Prognostic Value of the Right Ventricular Function by Portable Ultrasound in Patients With Pulmonary Hypertension View
NCT02112487 Extension of the Psychometric Validation Study ORCHESTRA in Patients With PAH View
NCT02126943 OPsumit USers Registry View
NCT02169752 Ambrisentan for the Improvement in Right Ventricular Strain in Scleroderma Associated Pulmonary Arterial Hypertension View
NCT03401476 Effect of Morphine on Dyspnea and 6-Minute Walk Distance in Pulmonary Arterial Hypertension View
NCT05439460 Management of Acute Pulmonary Hypertensive Crisis in Children With Known Pulmonary Arterial Hypertension View
NCT05452889 PET Image in PAH Patients View
NCT02243111 Detecting Pulmonary Arterial Hypertension PAH in Patients With Systemic Sclerosis SSc by Ultrasound View
NCT02246348 Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis SSc View
NCT05464095 The MObile Health InterVEntion in Pulmonary Arterial Hypertension MOVE PAH Study View
NCT02267200 The Screening and Analysis of Plasma Biomarkers in Irreversible PAH-CHD View
NCT02279160 Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension View
NCT02279745 Long-term Safety and Efficacy of Ralinepag in Pulmonary Arterial Hypertension View
NCT02276872 Safety Tolerability and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years View
NCT02284737 A Study to Investigate the Efficacy of PADN to Improved Functional Capacity and Hemodynamics in Patients With PAH View
NCT02304198 Clinical Trial to Evaluate the Long-term Safety of Udenafil in Patient With PAH View
NCT03795428 Long-Term Open Label Extension Study of Pemziviptadil PB1046 in PAH Subjects Following Completion of Study PB1046-PT-CL-0004 View
NCT02339961 Evaluating Pulmonary Arterial Hypertension in Patients With Systemic Sclerosis View
NCT03683082 Oxygen Treatment and Pulmonary Arterial Hypertension View
NCT03683186 A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension View
NCT05546125 a Non-interventional Study of Sildenafil in the Treatment of Pulmonary Arterial Hypertension PAH in Adults From China View
NCT05550389 Genetics of Pulmonary Hypertension View
NCT02391441 Ventricular Reversed Remodeling After LTX in PAH Patients View
NCT02403908 Catheter Denervation of Pulmonary Arteries in Treatment of IPAH SPAH View
NCT02436512 Study to Assess Acute Vasodilation Response of Inhaled Nitric Oxide View
NCT02435303 Effect of Sildenafil for Sustained PAH After MV Surgery SUPERIOR Trial View
NCT05584722 Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals View
NCT03810443 Prevalence of the Hyperventilation Syndrome in Pulmonary Arterial Hypertension View
NCT03707561 RUS-registry of PH View
NCT03550729 Effects of Physical Training on Vascular Function as a Therapeutic Target in Pulmonary Hypertension View
NCT02507011 Beta-blockers in Pulmonary Arterial Hypertension View
NCT02516722 TReatment Of Pulmonary HYpertension 1 Study View
NCT02530112 Functional Outcome Measures for Head and Neck Patients View
NCT01829672 Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography View
NCT02545465 A Study to Understand the Treatment Patterns in Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension During a Switch of Treatment to Adempas in Real-life Clinical Practice View
NCT05649748 An Extension Study of Treprostinil Palmitil Inhalation Powder TPIP for Pulmonary Arterial Hypertension PAH View
NCT05640128 Determination of Threshold Values of Aldosterone in HPLC-MSMS of Renin and of the Aldosterone Renin Ratio for the Diagnosis of Primary Hyperaldosteronism View
NCT05655481 Telerehabilitation Program Via Videoconference PAH - Randomized Clinical Trial View
NCT05665556 REgistry of Pulmonary Arterial Hypertension Associated With CONNECTIVE Tissue Diseases RECONNECTIVE View
NCT05679544 Biological Signatures Resulting From Occupational Exposure to Complex Mixtures of PAHs View
NCT02583906 Sleep Disordered Breathing in Precapillary Pulmonary Hypertension Effect of CPAP Treatment View
NCT03600415 Acute Exposure to High Altitude on Blood and Tissue Oxygenation ABGA NIRS View
NCT02664558 A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension WHO Group 1 View
NCT02682511 Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis SSc or SSc-associated Pulmonary Arterial Hypertension View
NCT04008550 Prognostic Impact of the Evolution of PAH 3 Months After TAVI HTP-TAVI View
NCT05745961 Quantifying 18kDa TSPO Expression in the Lung in Pulmonary Artery Hypertension PAH View
NCT03637179 Acute Exposure to High Altitude on Pulmonary Artery Pressure and Right Heart Function Echo Under Exercise View
NCT02725372 Clinical Study of Pulsed Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH View
NCT03780803 Effect of Home Rehabilitation on State of Patients With PAH HFREF and IHD View
NCT01824290 A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension PAH View
NCT03782818 Olaparib for PAH a Multicenter Clinical Trial View
NCT03655704 Apabetalone for Pulmonary Arterial Hypertension a Pilot Study View
NCT02782026 Exhaled Breath Olfactory Signature of Pulmonary Arterial Hypertension View
NCT02784808 Retrospective Analysis of Pulmonary Arterial Hypertension PAH and Related Complications in Juvenile Idiopathic Arthritis JIA Participants Treated With Biologic and Non-biologic Disease-modifying Anti-rheumatic Drugs DMARDs View
NCT05818137 A Study of Sotatercept in Japanese Pulmonary Arterial Hypertension PAH Participants MK-7962-020 View
NCT03978377 Cardiopulmonary Toxicity of Thoracic Radiotherapy View
NCT04062565 Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH View
NCT03858101 SNAP Study Nutrients in Adult PKU View
NCT05828147 Anti-CD20 Antibodies for Treatment of SLE-PAH View
NCT03893500 Utility of At-home Monitoring of Exercise Capacity by App-based 6-minute Walk Test View
NCT05825417 Pulmonary Hypertension Intensification and Personalisation of Combination Rx View
NCT02826252 Examination of Ventavis Iloprost Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μgmL V10 to 20 μgmL V20 View
NCT02823340 Fractionated Microneedle Radiofrequency for Treatment of Primary Axillary Hyperhidrosis View
NCT05843461 PIMR and Pulmonary Vascular Disease View
NCT02835950 TReatment Of Pulmonary HYpertension 1-US Study View
NCT02847260 Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin Therapy in PAH Subjects RAPID View
NCT02858791 MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial Hypertension View
NCT05861479 Prognostic Value of Estimated Plasma Volume in Pulmonary Hypertension View
NCT02886793 Cell Proliferation in Pulmonary Hypertension FDG-PET Comparison Between Patients and Healthy Subjects View
NCT02885012 Crossover Study From Macitentan or Bosentan Over to Ambrisentan View
NCT02889315 LenusPro Pump in PAH Treated With Treprostinil View
NCT02882126 An Open Label Extension Study to Evaluate the Safety of Continued Therapy of Subcutanous Remodulin in Pulmonary Arterial Hypertension View
NCT02891850 Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy View
NCT02927366 Safety Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients View
NCT04451850 HRV as a Marker of Treatment Response in PAH Arterial Hypertension View
NCT05908019 The Effects of Pulmonary Hypertension Web-Based Health Care Program on Symptom Management Social Support Activity Tolerance and Quality of Life in Patients With Pulmonary Hypertension View
NCT02932410 A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension PAH View
NCT04452513 A Prospective Clinical Study of Phenylketonuria PKU View
NCT05343637 A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hypertension View
NCT02939599 Long-term Extension Study of the Safety and Pharmacokinetics of QCC374 in PAH Patients View
NCT02959723 Physiopathology of Pulmonary Arterial Hypertension Mechanistic Studies View
NCT02968901 Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension OPTIMA View
NCT04316143 Pharmacokinetics Safety and Efficacy of BIA 5-1058 in PAH Zamicastat View
NCT02981082 Dimethyl Fumarate DMF in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension View
NCT04554160 Arrhythmias in Pulmonary Hypertension Assessed by Continuous Long-term Cardiac Monitoring View
NCT02999906 Study to Compare Triple Therapy Oral Treprostinil Ambrisentan and Tadalafil With Dual Therapy Ambrisentan Tadalafil and Placebo in Subjects With Pulmonary Arterial Hypertension View
NCT03016468 Safety of Transition From Selexipag to Remodulin Then Oral Treprostinil in Symptomatic Adult PAH View
NCT05958784 PKU Carriers Trial Pilot Study Impact on Cognition Mental Health Blood Pressure and Metabolism View
NCT03045029 ADAPT - A Patient Registry of the Real-world Use of Orenitram View
NCT03057028 Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension View
NCT05972629 A Phase 1Phase 2 Open-label Study to Evaluate the Safety Tolerability and Efficacy of a Single Intravenous Administration of SAR444836 in Adult Participants With Phenylketonuria View
NCT03068130 Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER View
NCT03069716 A Mobile Health Intervention in Pulmonary Arterial Hypertension View
NCT03105934 Repeatability of OCT and IV-US in Pulmonary Arterial Hypertension View
NCT04570228 TROPHY PAH Pivotal Study - TReatment of Pulmonary HYpertension for PAH Pivotal Study View
NCT03185364 The Safety and Efficiency of Sildenafil in the Treatment of Severe Post-capillary Pulmonary Hypertension Caused by COPD View
NCT03229499 Pulmonary Hypertension and Anastrozole Trial View
NCT03235401 The PAH Disability and Bothersomeness Questionnaire View
NCT04578223 Platelet Reactivity and Treatment With Prostacyclin Analogues in Pulmonary Arterial Hypertension View
NCT03288025 Pulmonary Arterial Hypertension Improvement With Nutrition and Exercise PHINE View
NCT03282266 Safety and Efficacy of Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension View
NCT03293407 Evaluation of Inhaled Iloprost Effects Using the Breelib Nebulizer on Clinical Outcomes and Physical Activity of Patients With Advanced Pulmonary Arterial Hypertension View
NCT03315507 A Study to Assess the Safety Tolerability and Hemodynamic Response of PB1046 in Subjects With PAH View
NCT02530996 Systemic Sclerosis SSc Vasculopathy Improved Clinical Monitoring and Treatment View
NCT04610788 Cardiac Assessment by PV Loop in IPAH and Scleroderma PAH View
NCT03399604 Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil View
NCT04896008 A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality MK-7962-006ZENITH View
NCT05421949 Assessing the Repeatability of NT-proBNP Testing Using Laboratory and Point of Care Testing in PAH View
NCT04796337 A Long-term Follow-up Study of Sotatercept for PAH Treatment MK-7962-004A011-12 View
NCT00586794 Therapy of Pulmonary Arterial Hypertension PAH - Treatment With Sildenafil in Eisenmenger Patients View
NCT03422328 A Clinical Study to Investigate the Long-term Safety of the Drug Macitentan in Patients With Pulmonary Hypertension Who Were Previously Treated With Macitentan in Clinical Studies View
NCT03429348 Evaluation of Post-Exposure Sauna Treatment of Firefighters - A Pilot Study View
NCT06196801 Efficacy of Triple-Combination Therapy in Severe PAH-CHD View
NCT03449524 PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension PAH View
NCT04811092 Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants MK-7962-005A011-13 View
NCT03497689 EXPEDITE A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension View
NCT03523910 Right Ventricular Pulmonary Vascular Interaction in Pulmonary Hypertension View
NCT03528902 Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension View
NCT03522935 Subcutaneous Elafin in Healthy Subjects View
NCT03574675 Acute Exposure of Simulated Hypoxia on Cardiac Output View
NCT03592979 Acute Exposure of Simulated Hypoxia on Heart Rate and Ventilation During Exercise View
NCT03593083 Acute Excposure of High Altitude on ECG and Non-invasive Blood Pressure View
NCT01392469 Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants View
NCT03602781 Study of PAH Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Nitric View
NCT01392495 Extension to CQTI571A2102 to Evaluate Long-term Safety Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension PAH View
NCT03637166 Acute Exposure to High Altitude on Pulmonary Artery Pressure and Right Heart Function Echo View
NCT04712669 A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension ELEVATE 2 View
NCT03631667 Ultralow Dose PAH Binary Mixture Study View
NCT03637140 Acute Exposure of Simulated Hypoxia on Pulmonary Artery Pressure and Right Heart Function Echo Under Exercise View
NCT03657095 A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension View
NCT03688698 PETMRI in PAH Patients View
NCT04744584 Medication Reconciliation in Pulmonary Hypertension View
NCT04745000 Observational Study of Actigraphy in Pediatric Pulmonary Arterial Hypertension View
NCT03738150 A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension View
NCT06384534 Exercise Performance on Ambient Air vs Low-Flow Oxygen Therapy in Pulmonary Vascular Disease PVD View
NCT04756076 Study Roles of Heavy Metals and Essential Metal Dyshomeostasis in Pulmonary Arterial Hypertension Patients View
NCT03777826 Effects of Synergy on Nutrient Intake and Acceptability in Phenylketonuria PKU View
NCT01847716 Transforming Growth Factor Beta Signalling in the Development of Muscle Weakness in Pulmonary Arterial Hypertension View
NCT03789643 Study to Evaluate Efficacy and Safety of JTT-251 in Participants With Pulmonary Arterial Hypertension View
NCT03802721 Pharmacokinetics of BenzoaPyrene Impact of Diet View
NCT05222178 Safety and Efficacy of HMI-103 in Participants With Classical PKU Due to PAH Deficiency View
NCT03838445 Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension RELIEVE-PAH View
NCT03833323 Implantable System for Remodulin Post-Approval Study View
NCT03863990 Study Performed at Various Medical Centers to Learn More About Survival and Expected Course of Pulmonary Arterial Hypertension a Type of High Blood Pressure in the Lungs Related to the Narrowing of the Small Blood Vessels in the Lungs View
NCT03888365 Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH View
NCT03884465 Hemodynamic Evaluation of Dose-response and Safety of Dry Powder Inhalation of Treprostinil View
NCT06454422 Implementing the Wuqinxi on Patients With Pulmonary Arterial Hypertension View
NCT03905421 Quality of Life Assessed With the PAH SYMPACT Questionnaire View
NCT03914859 IMPACT OF POLYCYCLIC AROMATIC HYDROCARBONS PAH ON IN VITRO FERTILIZATION View
NCT06481852 A Placebo-controlled Randomized Clinical Trial to Assess the Safety Feasibility and Pharmacokinetics of Microbiota Transplant Therapy With Antibiotic Preconditioning and Fiber Supplementation in Patients With Pulmonary Arterial Hypertension View
NCT03926793 Clinical Study of Inhaled GB002 for Treatment of WHO Group I Pulmonary Arterial Hypertension View
NCT03933579 The PAH Platform for Deep Phenotyping in Korean Subjects View
NCT03952156 Gene Therapy Clinical Study in Adult PKU View
NCT04996082 Skin Fibrosis Analysis by Raman Spectroscopy in Systemic Sclerosis View
NCT03977428 Central China Congenital Heart Disease Associated Pulmonary Arterial Hypertension Cohort Study View
NCT04019600 Screening of Pulmonary Hypertension in Methamphetamine Abusers View
NCT04039464 Mono vs Dual Therapy for Pediatric Pulmonary Arterial Hypertension View
NCT04076241 Effects of Adding Yoga Respiratory Training to Osteopathic Manipulative Treatment in Pulmonary Arterial Hypertension View
NCT04094272 Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection View
NCT05203510 A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension View
NCT04104490 Angiotensin Converting Enzyme ACE2 Brain Gut Dysbiosis in Pulmonary Hypertension View
NCT05065359 Multiple-Ascending Dose in Japanese Patients Bridging Study View
NCT04207593 The Effect of Oxygen Therapy on 6MWD in PAH and CTEPH Patients With Hypoxemia View
NCT05643014 Observational Study of Exposure to Environmental Toxicants Among Firefighters View
NCT06582459 Efficacy and Safety of High-Flow Nasal Cannula Versus Noninvasive Ventilation for Pulmonary Arterial Hypertension-Associated Acute Respiratory Failure View
NCT04273945 Outcome Study Assessing a 75 Milligrams mg Dose of Macitentan in Patients With Pulmonary Arterial Hypertension View
NCT04282434 DNA Methylation Dynamics Underlying Arterial Remodeling in PAH Patients CLEOPAHTRA Clinical Trial View
NCT04297371 Early Detection of Cardiac Impairment and Prediction of RV Hypertrophy in Patients With CTD View
NCT04309838 Observation Study With Implantable Medication Pump for Intravenous Treprostinil Therapy in Patients With Pulmonary Arterial Hypertension View
NCT04348708 Long-Term Follow Up Study of Subjects Previously Administered HMI 102 View
NCT05901168 Acute Responses of Active Video Games and Traditional Exercise Program in in Patients With Pulmonary Hypertension View
NCT05753254 Effect on Markers of Cardiovascular Reproductive and Cancer Risk From Firefighting Training View
NCT04435782 A Study of Selexipag Assessing Right Ventricular Remodeling in Pulmonary Arterial Hypertension by Cardiac Magnetic Resonance Imaging View
NCT03954405 Multi-marker Approach for Risk Assessment in PAH View
NCT04480567 AAV Gene Therapy Study for Subjects With PKU View
NCT04489251 Assessment of the TGF-beta Pathway and Micro-RNA in Pediatric Pulmonary Arterial Hypertension View
NCT03166306 Angiogenic Imaging in Pulmonary Arterial Hypertension View
NCT04528056 Pilot Study of the Safety and Efficacy of Sulfasalazine in Pulmonary Arterial Hypertension View
NCT01861548 Polish Mother and Child Cohort Study REPRO_PL - Follow up of the Children View
NCT04576988 A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension MK-7962-003A011-11STELLAR View
NCT05812976 Novel Index PIMR in PAH View
NCT04589390 Selexipag for the Treatment of Schistosomiasis-Associated Pulmonary Arterial Hypertension View
NCT05953220 Investigating Exposure to Toxicants From Smoking and Vaping View
NCT05967299 Study of Intravenous ZMA001 in Healthy Subjects View
NCT04677608 Pulmonary Hypertension Modality of Death and Validation of REVEAL Risk Score View
NCT03689244 A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or PersistentRecurrent After Surgery andor Interventional Treatment View
NCT04691154 A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD View
NCT04778046 Pulmonary Hypertension SOLAR View
NCT04791514 A Study of Treprostinil Palmitil Inhalation Powder TPIP In Pulmonary Arterial Hypertension PAH View
NCT04816604 Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension PAH View
NCT06332807 AAV Gene Therapy Clinical Study in Adult Classic PKU PHEdom View
NCT06061614 Safety and Efficacy Study of NGGT002 in PKU Adult Subjects View
NCT02536534 Electronic Activity Level Monitoring Pilot in Pulmonary Hypertension View
NCT04884971 Microbiota Transplant Therapy for Pulmonary Arterial Hypertension Early Safety and Feasibility Study View
NCT04903730 Safety Tolerability Pharmacokinetics Study of Single Multiple Inhaled Doses of Imatinib Inhalation Solution View
NCT04933071 ObGyn Residency Podcast Curriculum View
NCT06350032 Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH View
NCT05006118 Pharmacokinetics and Excretion of Oral 14C-Rodatristat Ethyl View
NCT05036135 A Study of AV-101 Dry Powder Inhaled Imatinib in Patients With Pulmonary Arterial Hypertension PAH View
NCT05056532 Evaluation of Respiratory Muscle in Patient With Pulmonary Arterial Hypertension View
NCT05063266 Effects of Inspiratory Muscle Training in Pulmonary Hypertensive Patient View
NCT05124015 Exercise Capacity Respiratory Muscle Strength Dyspnea and Physical Activity in Pediatric Pulmonary Arterial Hypertension View
NCT05135000 Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension View
NCT06172790 The Effects of the Otago Exercise Program View
NCT05417373 Algorithms to Diagnose Pulmonary Arterial Hypertension View
NCT05179876 A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option View
NCT06317805 Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients View
NCT05242380 Exercise Training in Patients With Pulmonary Arterial Hypertension View
NCT05256966 Firefighter Soot Sauna and Sweat Excretion Pilot Study View
NCT06643143 A Phase 2 Study of IkT-001Pro in Pulmonary Arterial Hypertension PAH View
NCT01897740 Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With Sildenafil View
NCT06543745 Safety and Impact of Low Resistance Exercise Training on Quality of Life in Pulmonary Arterial Hypertension View
NCT06649110 A Study to Learn About the Treatment LTP001 in Healthy Participants Part A and in Participants With PAH Part B View
NCT05339386 Developing Hyperpolarized 129Xe MRI Biomarkers for Evaluation of Pulmonary Arterial Hypertension View
NCT05337943 Cognitive Behavioral Therapy and Light Therapy View
NCT05339087 Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH View
NCT06550648 Evaluation of the Role of Epstein-Bar Virus in Patients With Pulmonary Arterial Hypertension View
NCT06605326 Subcutaneous Treprostinil as a Bridge to Lung Transplantation in Severe Pulmonary Hypertension A Single-Arm Retrospective Study View
NCT01907295 National Cohort Study of Idiopathic and Heritable Pulmonary Arterial Hypertension View
NCT05447390 Evaluation of the Strength of Handgrip in Patients With Pulmonary Artery Hypertension View
NCT05462574 Right Ventricle Lipid in Pulmonary Arterial Hypertension PAH View
NCT02587325 Phase 11b Study With Nab-sirolimus for Patients With Severe Pulmonary Arterial Hypertension View
NCT00621075 Correlation OF Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans View
NCT06567379 Myocardial Work Evaluation in Patients With PAH View
NCT05521113 Home-based Pulmonary Rehabilitation With Remote Monitoring in Pulmonary Arterial Hypertension View
NCT00626665 Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynauds Phenomenon in Scleroderma View
NCT05557942 Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension IMPAHCT-FUL View
NCT05569655 Efficacy and Safety Evaluation of Tolvaptan in the Treatment of Patients With RHF Caused by PAH View
NCT05564637 A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension View
NCT05587712 Study to Evaluate Sotatercept MK-7962 in Children With Pulmonary Arterial Hypertension PAH MK-7962-008 View
NCT05587400 Consistency of Electrical Cardiometry and Pulmonary Artery Catheter View
NCT01965691 Protein Requirements in Children With Phenylketonuria PKU View
NCT01966302 Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension PAH View
NCT05679570 Satralizumab in the Treatment of Pulmonary Arterial Hypertension SATISFY-JP Trial View
NCT02007629 Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitor View
NCT00080457 Safety and Efficacy Study of Sitaxentan Sodium Thelin in Patients With Pulmonary Arterial Hypertension View
NCT06587074 Features of the Clinical Course and Prognosis in Patients With Idiopathic Pulmonary Hypertension When Using Modern Strategies of Specific Therapy View
NCT00832507 Study of Cicletanine for Pulmonary Arterial Hypertension PAH View
NCT00840463 Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan View
NCT05764265 Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants View
NCT05767918 StratosPHere Non-interventional Study View
NCT05789407 Organic Pollutants in Pelvic Endometriosis View
NCT05798923 A Phase 2a Study of LAM-001 for the Treatment of Pulmonary Hypertension View
NCT02036970 Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension PH - LARIAT View
NCT02042014 Open-label Multi-center Protocol to Provide QTI571 to PAH Patients Who Participated in the Extension Study A2301E1 in Japan View
NCT00147199 Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension PAH View
NCT02734953 Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH View
NCT05934526 Efficacy and Safety of Seralutinib in Adult Subjects With PAH PROSERA View
NCT05948644 The Safety Tolerability and Pharmacokinetics of TPN171H Tablets in Patients With Pulmonary Arterial Hypertension View
NCT05967754 Correlation Between Serum Uric Acid and Pulmonary Hypertension in Obstructive Sleep Apnea Syndrome View
NCT05977933 Assessing the Utility of Submaximal CPET in Treatment Management of PAH View
NCT05975905 A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension PAH TROPOS Study View
NCT01038284 Multidisciplinary Collaboration Care in Pulmonary Arterial Hypertension PAH View
NCT06009185 Safety and Efficacy of BIA 5-1058 in PAH View
NCT01054105 Effect of BMPR-2 Gene Mutations on Hemodynamic Response by Iloprost Inhalation in Pulmonary Arterial Hypertension View
NCT06035861 Endothelial Cell Activation and Total Pulmonary Resistance in PAH View
NCT01092559 Pilot Study Evaluating the Safety and Performance of the GeNO NITROsyl Delivery System for Inhaled Nitric Oxide View
NCT06104228 129 Xenon MRI As a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension PAH View
NCT06122922 Xenon MRI in Stable Pulmonary Hypertension Jupiter AUGEAN View
NCT06137742 A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension View
NCT01178073 A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension PAH View
NCT01185730 Prospective Longitudinal Study of Patients With Idiopathic Pulmonary Arterial Hypertension Family or Taking Anorectics View
NCT01204853 A 12 Week Safety And Efficacy Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients View
NCT01274026 Evaluation of Behavior Executive Function Neurotransmitter Function and Genomic Expression Kuvan Nonresponders View
NCT01320865 Biomarkers in Pulmonary Arterial Hypertension Treated With Nilotinib View
NCT01321073 DelIVery for Pulmonary Arterial Hypertension PAH Continued Support Study View
NCT06351345 129 Xenon Imaging in Patients Treated With Sotatercept View
NCT06365372 Circulating MrgD in Pulmonary Hypertension View
NCT01389271 Inhaled Iloprost in the Treatment of Patients With Pulmonary Hypertension up to 4 Years View
NCT01439048 Placental and Cord Blood Markers Associated With Premature Birth and Disorders of Premature Birth in Newborn Infants View
NCT06445673 A Prospective Non-interventional Observational Study to Observe Long-term Treatment and Outcomes in Pulmonary Arterial Hypertension PAH Patients View
NCT01458236 A Multinational Multicenter Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist andor a Phosphodiesterase-5 Inhibitor View
NCT02060487 Effects of Oral Sildenafil on Mortality in Adults With PAH View
NCT02074449 Study Of Right Ventricular Performance In PAH Patients Treated With Rapid Dose Treprostinil Remodulin View
NCT06493461 A Study of HS135 for the Treatment of Pulmonary Arterial Hypertension in Adults View
NCT06477640 Home Rehabilitation Improves Cardiac Effort in Pulmonary Arterial Hypertension View
NCT02081690 A Pulmonary Arterial Hypertension Study With Macitentan to Validate the PAH-SYMPACT in France Italy and Spain View
NCT00660179 Study of Macitentan ACT-064992 on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension View
NCT02428985 Prospective Non-interventional Multi-center Post-authorization Safety Study of Riociguat for Pulmonary Arterial Hypertension PAH View
NCT02102672 Trimetazidine in Pulmonary Artery Hypertension View
NCT03942211 A Study in Participants With Sarcoidosis-associated Pulmonary Hypertension SAPH to Assess the Efficacy and Safety of Oral Selexipag View
NCT00266162 Bosentan in Treatment of Pulmonary Arterial Hypertension View
NCT00810693 A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension PAH View
NCT02736149 Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension WHO Group 1 View
NCT00811018 A Long-Term Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension View
NCT03637192 Acute Exposure of High Altitude on Cognitive Function View
NCT00800592 Sildenafil IV Bolus Study View
NCT03638908 Fluoxetine in Pulmonary Arterial Hypertension PAH Trial View
NCT00159861 The Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol in PAH View
NCT02825160 Non-interventional Postauthorization Safety Study of Ventavis for Pulmonary Arterial Hypertension PAH View
NCT01929213 Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Bosentan After Oral Administration View
NCT03950739 Open-label Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso View
NCT05256082 Impact of Face Masks on 6MWD in Patients With Pulmonary Hypertension View
NCT01028651 A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension View
NCT01548950 Drug Therapy and Surgery in Congenital Heart Disease With Pulmonary Hypertension View
NCT02705807 Evaluation of a New Thermostable Formulation of FLOLAN in Japanese Subjects View
NCT00878943 Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 Study View
NCT00902603 Ventavis Registry Protocol View
NCT02207868 3D Echo Evaluation of the Ventricles in Sclero Associated Severe PAH View
NCT01042158 A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis View
NCT01121458 Clevidipine for Vasoreactivity Evaluation of the Pulmonary Arterial Bed View
NCT01179334 Evaluation of the Pharmacodynamic Effect of the Combination of Sildenafil and Riociguat on Blood Pressure and Other Safety Parameters View
NCT01209819 Bone Mineral Density in Adults With Hyperphenylalaninemia View
NCT02234141 Selonsertib in Adults With Pulmonary Arterial Hypertension View
NCT01246037 Beta-blockers in i-PAH View
NCT01305252 A 48-week Study of the Effect of Dual Therapy Inhaled Treprostinil and Tadafafil Versus Monotherapy Tadalafil View
NCT02249923 Pediatric Pulmonary Hypertension Network PPHNet Informatics Registry View
NCT01332331 Efficacy and Safety of Ambrisentan in Children 8-18yrs View
NCT01342952 Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529 View
NCT01352026 Evaluation of Metformin Activity in Addition to Conventional Treatment of Grade II or III Pulmonary Arterial Hypertension PAH View
NCT01452971 A Study of the Interaction Between Tumor Susceptibility Gene Glycine N-methyltransferase GNMT and Lung Cancer View
NCT01465100 Liver Cell Transplant for Phenylketonuria View
NCT01477333 Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso View
NCT01520493 Peripheral Muscle Microcirculation and Exercise-induced Blood Flow Distribution in Pulmonary Arterial Hypertension View
NCT04130243 Biomarkers in Pediatric Congenital Heart Disease and PAH View
NCT05413109 COMPression of Left Main coRonary artEry in patientS With Pulmonary Arterial Hypertension aSymptomatIc fOr aNgina View
NCT02278445 Evaluation of Pulmonary Doppler Signals in Patients With Systemic SclerosisSSc View
NCT00169741 Renogram Study With Percutaneous Nephrolithotomy PERC Alterations in Renal Blood Flow as a Consequence of PERC View
NCT00303459 Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension PAH View
NCT00302211 The VISION Trial Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertension View
NCT02318186 Pharmacokinetic Study of Sub-q and IV Treprostinil in Kids With Pulmonary Arterial Hypertension PAH View
NCT00310830 Efficacy and Safety of Bosentan in Sickle Cell Disease SCD Patients With Pulmonary Arterial Hypertension PAH View
NCT00070590 Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma View
NCT00313222 Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary Hypertension View
NCT00325403 FREEDOM - M Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension PAH View
NCT00325442 FREEDOM-C Oral Treprostinil in Combination With an Endothelin Receptor Antagonist ERA andor a Phosphodiesterase-5 PDE-5 Inhibitor for the Treatment of Pulmonary Arterial Hypertension PAH View
NCT00506831 Imatinib in Systemic Sclerosis View
NCT00540436 Evaluate the Efficacy Safety and Pharmacokinetics of GSK1325760A in the Treatment of Pulmonary Arterial Hypertension View
NCT00566423 Biomarkers in the Diagnosis and Assessment of Pulmonary Arterial Hypertension PAH View
NCT00578786 A Long Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 NCT00423748 or AMB-321 NCT00423202 View
NCT00595049 Pulmonary Artery Remodelling With Bosentan View
NCT00593905 Pharmacogenomics in Pulmonary Arterial Hypertension View
NCT00617305 Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor PDE5i Therapy in Pulmonary Arterial Hypertension ATHENA-1 View
NCT00760916 FREEDOM DR Oral Treprostinil in Combination With an Endothelin Receptor Antagonist ERA andor a Phosphodiesterase-5 PDE-5 Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension PAH View
NCT00780728 Study Evaluating the Addition of Sildenafil to Bosentan Therapy in Pulmonary Arterial Hypertension View
NCT00781885 A Multi-Center Open-Label Multiple Dose Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH Patients View
NCT00887978 Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension View
NCT02484807 Effect of Pharmacologic Interaction Between ERAs and PDE-5 Inhibitors on Medication Serum Levels and Clinical Disease Status in Patients With PAH View
NCT02562235 Riociguat in Children With Pulmonary Arterial Hypertension PAH View
NCT02677870 The Effectiveness of Kuvan in Amish PKU Patients View
NCT02790450 Acute Effects of Benzbromaron on the Pulmonary Circulation View
NCT02885155 Contribution of Echocardiography to Prognostic Evaluation of Pulmonary Arterial Hypertension View
NCT02898155 Potentially Avoidable Hospitalisation in France View
NCT02893995 Safety Tolerability Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin Dose Titration in Pulmonary Arterial Hypertension View
NCT02958358 FDG Uptake and Lung Blood Flow in PAH Before and After Treatment With Ambrisentan View
NCT02961023 The Effect of Adding Exercise Training to Optimal Therapy in PAH View
NCT02970851 Bosentan in Myocardium Metabolism and Perfusion Measured by 18F-FDG and 82Rb PETCT on PAH and CTEPH View
NCT02997683 3-Month Home-based Training With Whole Body Vibration Device in Patients With PAH GALILEO-PAH-HOME View
NCT03078192 Non-Invasive Diagnosis of Pulmonary Vascular Disease Using Inhaled 129Xe Magnetic Resonance Imaging View
NCT03145298 ALlogeneic Cardiosphere-derived Stem Cells CDCs for Pulmonary Hypertension therApy View
NCT03177603 A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension PAH View
NCT03187678 Safety Study of the Switch From Oral Selexipag to Intravenous Selexipag in Subjects With Stable Pulmonary Arterial Hypertension View
NCT03234790 Human Study to Develop a Signature of Occupational Diesel Exhaust Exposure View
NCT03304548 Qualitative Research to Explore Treatment Preference in Pulmonary Arterial Hypertension PAH Subjects View
NCT03368261 Epidemiology and Pathophysiological Mechanisms of HTAP in SS and SC Children in Martinique and Guadeloupe View
NCT03389321 Clinical Study to Investigate Effect of Macitentan on Riociguat Pharmacokinetics View
NCT03446339 Pulmonary Hypertension Screening for Rheumatology Patients SOPHIE View
NCT03496207 A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension PAH View
NCT03492177 A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension View
NCT03556020 Phase 2 Study to Assess Safety Tolerability and Efficacy of Once Weekly SC Pemziviptadil PB1046 in Subjects With Symptomatic PAH View
NCT03593096 Acute Exposure to High Altitude on Heart Rate and Ventilation During Exercise View
NCT03592927 Acute Exposure to Simulated Hypoxia on Exercise Capacity View
NCT03617458 Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension View
NCT03626688 A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients View
NCT03637114 Acute Exposure of Simulated Hypoxia on Blood and Tissue Oxygenation aBGA NIRS View
NCT03718780 Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exercise View
NCT03754660 This Study Tests the Safety of Inhaled BAY1237592 How the Drug is Tolerated and How it Effects Patients With High Blood Pressure in the Arteries of the Lungs in the Two Different Disease Groups Pulmonary Arterial Hypertension PAH and Chronic Thromboembolic Pulmonary Hypertension CTEPH View
NCT03819777 Volatile Organic Compounds VOCs as a Biomarker in Immune-mediated Pulmonary Arterial Hypertension PAH View
NCT03835676 Effects of Treprostinil on Right Ventricular Structure and Function in Patients With Pulmonary Arterial Hypertension View
NCT03841344 Repeatability and Sensitivity to Change of Non-invasive Endpoints in PAH View
NCT03904693 Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension PAH View
NCT03924154 A Study of RVT-1201 in Patients With Pulmonary Arterial Hypertension ELEVATE 1 View
NCT03939052 Protein Requirements in Adults With Phenylketonuria PKU View
NCT03992755 Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil View
NCT04053543 CXA-10 Study in Subjects With Pulmonary Arterial Hypertension View
NCT04071327 Pulmonary Hypertension Association Registry View
NCT04086537 BMPR2 Mutations and Iron Metabolism in Pulmonary Arterial Hypertension View